Atellica IM CsA 10995548Recalls & reported problems
Siemens Healthcare Diagnostics Inc. · Cyclosporine (CsA) Atellica IM - RGT 50T · Class 2
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 2
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 00630414598727), received between Jan 20, 2026 and Jan 20, 2026 — classified as 2 malfunctions.
The most frequently reported specific device problem is “Low Test Results” (2 reports).
1 other recall cover devices cleared under the same FDA submission (K071455); they may or may not involve this specific model.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Most reported problems
Device problems
- Low Test Results2
Patient problems
- No Clinical Signs, Symptoms or Conditions2
Recent adverse event reports
The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.
MalfunctionJan 20, 2026Low Test Results
THE CUSTOMER COMPLAINED OF LOW ATELLICA IM CYCLOSPORINE (CSA) LOT 055 PATIENT RESULTS. A DISCORDANT RESULT WAS IDENTIFIED WHERE A PATIENT SAMPLE TESTED ON (B)(6) 2025 WITH ATELLICA IM CSA RESULTED LOWER THAN A RESULT FROM AN ALTERNATE METHOD OBTAINED AT A DIFFERENT LAB. THERE ARE NO REPORTS OF PATIENT OR USER INTERVENTION OR ADVERSE HEALTH CONSEQUENCES IN ASSOCIATION WITH THIS EVENT.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 24116830 ↗MalfunctionJan 20, 2026Low Test Results
THE CUSTOMER REPORTED DISCORDANT (LOW) ATELLICA IM CYCLOSPORINE (CSA) LOT 055 PATIENT RESULTS. THE CUSTOMER PROVIDED DATA FOR 2 PATIENT SAMPLES TESTED ON (B)(6) 2026 WHERE THE INITIAL ATELLICA IM CSA WERE LOWER THAN RESULTS FROM AN ALTERNATE METHOD OBTAINED AT A DIFFERENT LAB. THERE ARE NO REPORTS OF PATIENT OR USER INTERVENTION OR ADVERSE HEALTH CONSEQUENCES IN ASSOCIATION WITH THIS EVENT
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 24114920 ↗
Recalls under the same FDA submission
These recalls involve devices cleared under K071455. One submission often covers many models, so check the product and lot details in each record.
- Z-1687-2018 · Jan 2, 2018 · TerminatedADVIA Centaur Cyclosporine
Other CYCLOSPORINE devices
- Dimension® CSA Flex® reagent cartridge 10285193Siemens Healthcare Diagnostics Inc. · CYCLOSPORINE4 reports
- ADVIA Centaur® CsA 10335448Siemens Healthcare Diagnostics Inc. · CYCLOSPORINE1 report
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page